Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23) (NLTX)
New Form SCHEDULE 13G - Neurogene Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049481 Size: 21 KB
New Form SCHEDULE 13G - Neurogene Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049481 Size: 21 KB
There are no comments here yet...